Tevogen Inc.

TVGN

Tevogen Inc.

TVGN

Insider Sentiment (TTM):

Last Purchase:2024-06-12Last Sale:2026-03-13Shares Purchased (TTM):0Shares Sold (TTM):501

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:135,316Shares Outstanding:3,486,215Institutional Ownership Pct.:3.88%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Cash	1	1	1	1	1	2	1	2	1	1	1	0
Assets Current
Assets Current	2	2	2	2	2	3	2	4	2	2	2	0
Prepaid Expense And Other Assets Current	1	1	1	1	1	1	1	1	1	1	1	0
Assets Held In Trust Noncurrent	-	-	-	-	-	-	-	-	-	-	17	26
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	-
Operating Lease Right Of Use Asset	1	1	1	1	1	0	0	0	0	0	0	-
Deferred Costs	0	0	0	0	-	-	-	-	-	-	3	-
Accounts Payable And Accrued Liabilities Current	-	-	-	-	-	-	-	-	-	-	1	1
Other Assets Noncurrent	1	1	1	1	1	1	1	0	0	0	0	-
Assets	5	5	4	4	4	4	3	4	3	3	6	26
Liabilities And Stockhold…
Other Liabilities Current	-	-	-	-	-	-	-	-	-	-	0	0
Accounts Payable Current	3	4	3	3	4	5	5	6	7	5	3	-
Accrued Liabilities Current	1	1	1	1	2	2	2	1	2	2	1	-
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	-
Temporary Equity
Liabilities Current
Liabilities Current	6	7	7	7	8	9	9	10	11	9	85	2
Convertible Notes Payable Current	-	-	-	-	-	-	-	-	-	-	81	1
Temporary Equity Carrying Amount Attributable To P…	-	-	-	-	-	-	-	-	-	-	17	26
Notes Payable Current	2	2	2	2	2	2	2	2	2	2	-	-
Lines Of Credit Current	-	-	-	-	-	-	-	1	-	-	-	-
Convertible Long Term Notes Payable	-	-	-	-	-	-	-	-	-	-	14	-
Operating Lease Liability Noncurrent	1	1	1	1	1	-	0	0	0	0	0	-
Derivative Liabilities Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities	14	15	13	12	14	12	10	10	11	9	100	17
Preferred Stock Value	-	-	-	-	-	-	-	-	3	-	-	-
Stockholders Equity
Stockholders Equity	-9	-10	-8	-8	-9	-8	-7	-6	-8	-6	-94	-91
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	-
Additional Paid In Capital	133	126	123	118	111	107	98	91	88	76	5	-
Retained Earnings Accumulated Deficit	-151	-145	-140	-135	-129	-124	-113	-104	-98	-88	-100	-16
Liabilities And Stockholders Equity	5	5	4	4	4	4	3	4	3	3	6	26
Preferred Stock Par Or Stated Value Per Share	-	-	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Authorized	-	-	20	20	20	20	20	20	20	20	1	1
Preferred Stock Shares Issued	-	-	-	-	-	-	-	-	-	-	0	0
Preferred Stock Shares Outstanding	-	-	-	-	-	-	-	-	-	-	0	0
Common Stock Par Or Stated Value Per Share	0	0	0	0	0	0	0	0	0	0	0	-
Common Stock Shares Authorized	800	800	800	800	800	800	800	800	800	800	800	-
Common Stock Shares Issued	4	4	4	4	4	4	4	3	3	3	2	-
Shares Outstanding	4	4	4	4	4	4	4	3	3	3	2	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	31.70%	-27.42%	-15.47%	-	-	-	-	-	-	-	-	-
2025	30.00%	12.73%	-9.09%	-11.63%	-31.22%	-35.92%	-3.84%	-12.71%	-27.10%	67.04%	112.61%	109.29%
2024	0.88%	0.63%	-11.73%	-41.93%	-61.52%	226.90%	-26.47%	6.62%	8.09%	-7.29%	22.43%	12.15%
2023	-	-	-	0.47%	1.21%	1.68%	1.01%	1.83%	-61.47%	-18.00%	-20.00%	-20.20%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.33	0.29	0.22	0.31	0.25	0.35	0.26	0.34	0.23	0.27	0.02	0.22
Quick Ratio	0.20	0.12	0.10	0.18	0.10	0.24	0.16	0.24	0.12	0.17	0.01	0.19
Working Capital	-4.14M	-5.13M	-5.53M	-4.62M	-6.02M	-5.64M	-6.68M	-6.89M	-8.17M	-6.54M	-83.76M	-1.43M
Leverage & Debt
Debt to Equity	-1.53	-1.50	-1.53	-1.57	-1.45	-1.53	-1.52	-1.69	-1.43	-1.58	-1.06	-0.18
Interest Coverage TTM	-70.74	-87.46	-133.63	-219.51	-343.95	-651.25	-291.04	-58.82	-39.56	-26.25	-5.87	-4.75
Debt Ratio	2.88	3.00	2.88	2.74	3.22	2.90	2.93	2.44	3.31	2.73	18.15	0.63
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-5.61	-6.09	-7.91	-8.67	-10.38	-10.76	-4.68	-1.50	-1.01	-6.75	-122.17	-22.60
Free Cash Flow Per Share TTM	-3.17	-3.37	-3.71	-2.52	-3.05	-4.07	-4.09	-3.21	-2.89	-2.97	-16.77	-2.64
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	-37.15%	-38.92%	91.41%	565.03%	1,000.14%	80.79%	-77.30%	-90.58%	-93.62%	-27.00%	-1,471.89%	-3,172.15%
EPS Growth (1Y)	-45.95%	-43.44%	69.13%	477.32%	930.08%	53.83%	-96.17%	-93.36%	-95.04%	-36.21%	-2,012.17%	-1,020.37%
Valuation Metrics
P/E TTM	-1.01	-0.74	-2.09	-4.53	-6.02	-5.02	-11.01	-12.25	-35.89	-26.80	-4.56	-23.96
P/B TTM	-2.44	-1.60	-6.67	-19.67	-21.70	-22.58	-22.64	-10.12	-14.60	-88.75	-2.92	-14.31
Market Cap	21.67M	15.76M	54.94M	153.88M	205.82M	174.32M	151.07M	62.62M	111.46M	515.00M	275.49M	1.30B
Enterprise Value	22.24M	16.72M	56.04M	154.50M	206.78M	174.00M	151.44M	62.96M	111.98M	515.33M	369.37M	1.30B
Calculated Values
Free Cash Flow TTM	-12.14M	-11.75M	-12.33M	-9.89M	-10.04M	-13.14M	-12.00M	-10.93M	-8.92M	-8.16M	-8.30M	-6.34M
Net Debt	568.85K	958.70K	1.10M	613.91K	965.77K	-323.93K	368.01K	332.79K	515.61K	333.10K	93.88M	-1.98M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2026-03-13Sale

Owner: Flomenberg, Neal

Title: See Remarks

Shares: 501

Price/Share: $6.40

Value: $3,206.40

Shares Owned: 76,940

Relationship: Officer

Ownership: Direct

2025-06-09Sale

Owner: Saadi, Ryan H.

Title: Chief Executive Officer

Shares: 1,438,206

Price/Share: $1.23

Value: $1,768,993.38

Shares Owned: 116,814,453

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2025-03-12Sale

Owner: Flomenberg, Neal

Title: See Remarks

Shares: 232,968

Price/Share: $1.09

Value: $253,935.12

Shares Owned: 3,595,608

Relationship: Officer

Ownership: Direct

2025-03-11Sale

Owner: Flomenberg, Neal

Title: See Remarks

Shares: 70,252

Price/Share: $1.05

Value: $73,764.60

Shares Owned: 3,828,576

Relationship: Officer

Ownership: Direct

2025-03-06Sale

Owner: Flomenberg, Neal

Title: See Remarks

Shares: 88,519

Price/Share: $1.10

Value: $97,370.90

Shares Owned: 4,040,485

Relationship: Officer

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2026-03-13	Flomenberg, Neal	Officer	See Remarks	Direct	Sale	501	6.40	$3,206.40	76,940	4
2025-06-09	Saadi, Ryan H.	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Sale	1,438,206	1.23	$1,768,993.38	116,814,453	4
2025-03-12	Flomenberg, Neal	Officer	See Remarks	Direct	Sale	232,968	1.09	$253,935.12	3,595,608	4
2025-03-11	Flomenberg, Neal	Officer	See Remarks	Direct	Sale	70,252	1.05	$73,764.60	3,828,576	4
2025-03-06	Flomenberg, Neal	Officer	See Remarks	Direct	Sale	88,519	1.10	$97,370.90	4,040,485	4
2024-10-17	Flomenberg, Neal	Officer	See Remarks	Direct	Sale	1,078,600	1.62	$1,747,332.00	4,254,302	4
2024-06-12	Desai, Kirti	Officer	Chief Financial Officer	Direct	Purchase	3,000	0.82	$2,460.00	9,699,186	4
2024-06-05	Saadi, Ryan H.	Director,Officer,TenPercentOwner	Chief Executive Officer	Direct	Purchase	2,607	0.77	$2,007.64	118,252,659	4
2023-07-17	Corbin, Erisa Opportunity…	TenPercentOwner	-	Indirect	Sale	2,320,000	10.68	$24,777,600.00	0	4
2023-06-07	Semper, Paratus Sponsor L…	TenPercentOwner	-	Direct	Sale	8,988,889	1.00	$8,988,889.00	4,294,444	4
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

3.88%

Inst. Shares: 135,316

Shares Outstanding: 3,486,215

2025-12-31

150.08%

Inst. Shares: 4,982,252

Shares Outstanding: 3,319,812

2025-09-30

121.92%

Inst. Shares: 4,779,839

Shares Outstanding: 3,920,576

2025-06-30

128.12%

Inst. Shares: 4,722,613

Shares Outstanding: 3,686,143

2025-03-31

115.08%

Inst. Shares: 3,714,897

Shares Outstanding: 3,228,142

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	135,316	3,486,215	3.88%
2025-12-31	4,982,252	3,319,812	150.08%
2025-09-30	4,779,839	3,920,576	121.92%
2025-06-30	4,722,613	3,686,143	128.12%
2025-03-31	3,714,897	3,228,142	115.08%
2024-12-31	2,338,273	2,933,451	79.71%
2024-09-30	5,490,600	3,403,491	161.32%
2024-06-30	5,538,581	3,083,342	179.63%
2024-03-31	6,766,865	2,746,676	246.37%
2023-12-31	810,770	495,040	163.78%
2023-09-30	2,224,926	2,400,000	92.71%
2023-06-30	4,791,003	2,400,000	199.63%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Tevogen Inc. (TVGN) — SEC Financial Statements & Analysis

Tevogen Inc. (TVGN) is a biological products, (no diagnostic substances) company, incorporated in DE. Tevogen Inc. trades on Nasdaq as: TVGN, TVGNW. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Tevogen Inc. reported a Debt-to-Equity ratio of -1.53x, a Price-to-Book (P/B) ratio of -2.44x (TTM), at a market cap of $21.67M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: -1.53x
P/B TTM: -2.44x
Market Cap: $21.67M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Tevogen Inc. in?

Tevogen Inc. (TVGN) operates in the Biological Products, (No Diagnostic Substances) industry.

What is TVGN's market cap?

Tevogen Inc. (TVGN) has a market capitalization of $21.67M as of 2026-06-30.

What exchange does TVGN trade on?

Tevogen Inc. (TVGN) trades on the Nasdaq.

Where is Tevogen Inc. incorporated?

Tevogen Inc. is incorporated in DE.

Tevogen Inc.

Financial Statements

Custom Table

Interactive Financial Visualizations

Earnings Market Reaction

Performance and Valuation Metrics

Insider Transactions

Institutional Ownership

Tevogen Inc. (TVGN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.
Main Street's price.

Tevogen Inc. (TVGN) — SEC Financial Statements & Analysis

Frequently Asked Questions

Companies in Biological Products, (No Diagnostic Substances)

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.